On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Targeted Medical Pharma (United States)

InstitutionResearch output, impact & collaborations

Targeted Medical Pharma (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Targeted Medical Pharma (United States)?

ScholarIQrecord summary

Targeted Medical Pharma (United States) is a research organisation in Los Angeles, US. OpenAlex records 144 works and 14,150 citations for it. 49 researchers list it as their most recent affiliation.

How many works does Targeted Medical Pharma (United States) have?

ScholarIQindexed works

Targeted Medical Pharma (United States) has 144 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Targeted Medical Pharma (United States) have?

ScholarIQcitation count

Targeted Medical Pharma (United States) has 14,150 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Targeted Medical Pharma (United States)?

ScholarIQresearcher count

Targeted Medical Pharma (United States) has 49 researchers in the ScholarIQ index.

What is the average h-index at Targeted Medical Pharma (United States)?

ScholarIQavg h-index

Targeted Medical Pharma (United States) has an average h-index of 53 in OpenAlex.

What is the ROR of Targeted Medical Pharma (United States)?

ScholarIQror

The ROR for Targeted Medical Pharma (United States) is on the source record.

What is the OpenAlex record for Targeted Medical Pharma (United States)?

ScholarIQopenalex

The OpenAlex for Targeted Medical Pharma (United States) is on the source record.

Who are the most-cited researchers behind Targeted Medical Pharma (United States)?

ScholarIQtop researchers by citations
1
Raymond A. Dionne · Pain Mechanisms and Treatments
222 works18,812 citations

What are the most-cited papers on Targeted Medical Pharma (United States)?

ScholarIQmost cited works
Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations
Robert H. Dworkin, Dennis C. Turk, Kathleen W. Wyrwich, Dorcas Beaton, Charles S. Cleeland, John T. Farrar, Jennifer A. Haythornthwaite, Mark P. Jensen, Robert D. Kerns, Deborah N. Ader, Nancy A. Brandenburg, Laurie B. Burke, David Cella, Julie Chandler, Penny Cowan, Rozalina Dimitrova, Raymond A. Dionne, Sharon Hertz, Alejandro R. Jadad, Nathaniel P. Katz, Henrik Kehlet, Lynn D. Kramer, Donald C. Manning, Cynthia G. McCormick, Michael McDermott, Henry J McQuay, Sanjay Patel, Linda Porter, Steve Quessy, Bob A. Rappaport, Christine Rauschkolb, Dennis A. Revicki, Margaret Rothman, Kenneth E. Schmader, Brett R. Stacey, Joseph Stauffer, Thorsten von Stein, Richard E. White, James Witter, Stojan Zavisic
Journal of Pain. 20073,447 Citations

How much of the research on Targeted Medical Pharma (United States) is open access?

ScholarIQopen access share
0%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
0%
Closed
100%

Related on ScholarIQ

470M+ articles · 14-day free trial